Billy Dunn, former FDA neuroscience head, joins Prothena board
BioPharma
Stay updated with breaking news from Michael Yee. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A suit would mark the first time in more than a decade that the FTC has sought to stop a pharmaceutical deal outright.
The U.S. Federal Trade Commission said on Tuesday it has filed a lawsuit to stop Amgen Inc's $27.8 billion acquisition of Horizon Therapeutics Plc in a rare move to block a large pharmaceutical deal. ... | June 12, 2023
Operator: Hello, ladies and gentlemen. Thank you for standing by, and welcome to Zai Lab First Quarter 2023 Financial Results Conference Call.
Operator: Hello and thank you for standing by. My name is Andrew and I will be your conference operator today.